Skip to Main Content

INFORMATION FOR

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study (RELIEF)

Conditions

Pain Control

Phase IV

What is the purpose of this trial?

Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief.

  • Trial with
    W.L. Gore & Associates, Inc.
  • Start Date
    08/11/2022
  • End Date
    02/28/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000026580